Suppr超能文献

如何处理终末期脱水。

How to manage terminal dehydration.

作者信息

Suchner U, Reudelsterz C, Gog C

机构信息

Department of anesthesiology and intensive care, Klinikum Darmstadt, Darmstadt, Germany.

, Berlin, Germany.

出版信息

Anaesthesist. 2019 Feb;68(Suppl 1):63-75. doi: 10.1007/s00101-018-0527-1.

Abstract

Although dehydration is a serious condition associated with significant morbidity and mortality in palliative care patients, as in any other patient group, treatment remains controversial. A narrative review of the causes of dehydration during end of life was conducted paying special attention to the nature of terminal dehydration. A comprehensive search of the literature was performed to identify relevant articles published in English and German languages between 1960 and 2018. Currently available options for bed-side evaluation and therapeutic approaches were critically appraised and areas of future research are emphasized. The following inferences can be derived: 1) the available evidence does not support a clear decision in favor or against fluid therapy during the dying phase. 2) There is inadequate precision of the term end of life care (ELC) and insufficient differentiation between modes of dehydration of palliative care patients. 3) Evaluation of dehydration based on its clinical appearance is considered the method of choice compared to invasive procedures. 4) Detailed clinical assessment of symptom reversibility in terminal dehydration by an appropriate fluid challenge is mandatory in the decision-making process. 5) If despite adequate rehydration measures, complete reversibility of the clinical picture of dehydration can no longer be achieved since organ systems are gradually deteriorating, the cessation of clinically assisted hydration (CAH) can be considered. 6) If symptoms of dehydration are reversible after fluid challenge and no other patient wishes to the contrary are known, fluid management should be continued in the context of symptom control. 7) Hyperhydration represents a considerable threat during fluid management that needs to be prevented by noninvasive monitoring procedures. In conclusion, if CAH is applied as a part of ELC the hydration status needs to be individually appraised and all therapeutic measures constantly need to be adapted to the findings of diligent monitoring procedures.

摘要

尽管脱水是姑息治疗患者中一种与显著发病率和死亡率相关的严重状况,与其他任何患者群体一样,其治疗仍存在争议。本文对临终时脱水的原因进行了叙述性综述,特别关注终末期脱水的性质。对文献进行了全面检索,以确定1960年至2018年间以英文和德文发表的相关文章。对目前可用的床边评估和治疗方法选项进行了批判性评估,并强调了未来研究的领域。可得出以下推论:1)现有证据不支持在临终阶段对是否进行液体治疗做出明确的支持或反对决定。2)临终关怀(ELC)这一术语的精确性不足,姑息治疗患者脱水模式之间的区分也不够充分。3)与侵入性检查相比,基于临床表现评估脱水被认为是首选方法。4)在决策过程中,通过适当的液体激发试验对终末期脱水症状的可逆性进行详细的临床评估是必不可少的。5)如果尽管采取了充分的补液措施,但由于器官系统逐渐恶化,脱水的临床表现已无法完全逆转,则可考虑停止临床辅助补液(CAH)。6)如果液体激发试验后脱水症状可逆,且未发现患者有其他相反意愿,则应在症状控制的背景下继续进行液体管理。7)补液过多在液体管理过程中是一个相当大的威胁,需要通过非侵入性监测程序来预防。总之,如果将CAH作为ELC的一部分应用,则需要对补液状态进行个体化评估,并且所有治疗措施都需要不断根据仔细监测程序的结果进行调整。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验